Biomedical Engineering Reference
In-Depth Information
Wu P. G., Zhu J. H., Xu Z. H., et al. 2004. Template-assisted synthesis of mesoporous
magnetic nanocomposite particles. Adv. Funct. Mater. 14: 345-351.
Xie L., Dong B., Jiang Z., et al. 2011. Synthesis of novel core-shell structural AuNR@
MCM-41 die infrared light-driven release of drug. J. Mater. Res. 26: 2414-2419.
Xu Z., Gao Y., Huang S., et al. 2011. A luminescent and mesoporous core-shell struc-
tured Gd 2 O 3 :Eu 3+ @ n SiO 2 @ m SiO 2 nanocomposite as a drug carrier. Dalton Trans.
40: 4846-4854.
Xu Z., Li C., Ma P. A., et al. 2011. Facile synthesis of an up-conversion luminescent
and mesoporous Gd 2 O 3 :Er 3+ @ n SiO 2 @ m SiO 2 nanocomposite as a drug carrier.
Nanoscale 3: 661-667.
Yan P., Huang S., Kong D., et al. 2007. Luminescence functionalization of SBA-15 by
YVO4:Eu 3+ as a novel drug delivery system. Inorg. Chem. 46: 3203-3211.
Yang P., Gai S., Lin J. 2012. Functionalized mesoporous silica materials for controlled
drug delivery. Chem. Soc. Rev. 41: 3679-3698.
Yang P., Quan Z., Hou Z., et al. 2009. A magnetic, luminescent and mesoporous core-
shell structured composite materials as drug carrier. Biomaterials 30: 4786-4795.
Yang P., Quan Z., Li C., et al. 2008. Fabrication, characterization of spherical
CaWO4:Ln@MCM-41(Ln=Eu3+,Dy3+,Sm3+,Er3+) composites and their appli-
cations as drug release systems. Micropor. Mesopor. Mater. 116: 524-531.
Yang Y., Qu Y., Zhao J., et al. 2010. Fabrication of and drug delivery by an upconver-
sion emission nanocomposite with monodisperse LaF 3 :Yb,ER core/mesoporous
silica shell structure. Eur. J. Inorg. Chem. 5195-5199.
Yiu H. H. P., Niu H.-J., Biermans E., et al. 2010. Designed multifunctional nanocom-
posites for biomedical applications. Adv. Funct. Mater. 20: 1599-1609.
Zhang C., Hou T., Chen J. F., et al. 2010. Preparation of mesoporous silica micro-
spheres with multi-hollow cores and their application in sustained drug release.
Particuology 8: 447-452.
Zhang L., Qiao S. Z., Jin Y. G., et al. 2008. Magnetic hollow spheres of periodic meso-
porous organosilica and Fe3O4 nanocrystals: Fabrication and structure control.
Adv. Mater. 20: 805-809.
Zhang X., Clime L., Roberge H., et al. 2011. pH-triggered doxorubicin delivery based
on hollow nanoporous silica nanoparticles with free-standing superparamag-
netic Fe3O4 cores. J. Phys. Chem. C 115: 1436-1443.
Zhao W., Chen H., Li Y., et al. 2008. Cover picture: Uniform rattle-type hollow mag-
netic mesoporous spheres as drug delivery carriers and their sustained-release
property. Adv. Funct. Mater. 18: 2780-2788.
Zhao W., Gu J., Zhang L., et al. 2005. Fabrication of uniform magnetic nanocomposite
spheres with a magnetic core/mesoporous silica shell structure. J. Am. Chem.
Soc. 127: 8916-8917.
Zhao W., Lang M., Li Y., et al. 2009. Fabrication of uniform hollow mesoporous silica
spheres and ellipsoids of tunable size through a facile hard-templating route. J.
Mater. Chem. 19: 2778-2783.
Zhou J., Wu W., Caruntu D., et al. 2007. Synthesis of porous magnetic hollow silica
nanospheres for nanomedicine application. J. Phys. Chem. C. 111: 17473-17477.
Zhu Y., Fang Y., Borchardt L., et al. 2011. PEGylated hollow mesoporous silica
nanoparticles as potential drug delivery vehicles. Micropor. Mesopor. Mater. 141:
199-206.
Zhu Y., Fang Y., and Kaskel S. 2010. Folate-conjugated Fe 3 O 4 @SiO 2 hollow mesoporous
spheres for targeted anticancer drug delivery. J. Phys. Chem. C. 114: 16382-16388.
Search WWH ::




Custom Search